IP vs OVID · P/E 43, $26.62B cap vs rev $566.0K
International Paper (IP) versus Ovid Therapeutics Inc (OVID) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported OVID revenue for 2024-12-31 was $566.0K. Net income was -$26.4M. Revenue was up 44.4% from 2023-12-31 to 2024-12-31. OVID currently screens at market cap $23.5M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. OVID currently screens at market cap $23.5M.
Not investment advice. Open the IP and OVID stock pages for the full models.
Not investment advice.